Cargando…
Topical and intralesional therapies for in-transitmelanoma
This report surveys the role of topical and intralesional agents in the management of in-transit melanoma. The extent and progression of in-transit disease is highly variable and many patients can have a protracted period of locoregional control. These agents are useful in the management of patients...
Autor principal: | Henderson, Michael A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891934/ https://www.ncbi.nlm.nih.gov/pubmed/31807274 http://dx.doi.org/10.2217/mmt-2019-0008 |
Ejemplares similares
-
Topical and Intralesional Immunotherapy for Melanoma In Situ: A Review
por: Martínez-Fernández, Sandra, et al.
Publicado: (2023) -
Topical and Intralesional Immunotherapy for the Management of Skin Cancer in Special Locations: Lips and Eyelids
por: Buján Bonino, Cecilia, et al.
Publicado: (2023) -
The Anti-Psoriatic Efficacy and Safety Profile of Topical and Intralesional Methotrexate: A Literature Review
por: Chaiyabutr, Chayada, et al.
Publicado: (2022) -
Unusual presentation of angiolymphoid hyperplasia with eosinophilia treated with intralesional and topic corticosteroid combination therapy
por: Granieri, Giammarco, et al.
Publicado: (2021) -
A Compendium of Intralesional Therapies in Nail Disorders
por: Grover, Chander, et al.
Publicado: (2018)